Wasik N, et al. – This pilot study attempted to clarify the status of clusterin in subarachnoid haemorrhage (SAH). Researchers reported that SAH was related to an immediate reduction in CSF clusterin concentrations. They suggested that the clusterin level at one point was a good predictor of outcome and it could serve as a biomarker.